Caliper Life Sciences last week announced two separate deals, one with Yale University's Center for Genome Analysis and another with Erasmus University Medical Center, to automate sample prep for next-generation sequencing projects.

The company disclosed the agreements prior to PerkinElmer's announcement that it plans to acquire Caliper in a deal worth approximately $600 million (see related story, this issue).

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.